Bioactivity of the rhOSM was comparable to commercially available recombinant human OSM (chOSM) in human breast cancer cells as determined by an enzyme-linked immunosorbent assay (ELISA), which detected phosphorylation of STAT3. The gene discussed is OSM; the disease is breast carcinoma.